• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    n-Lorem Foundation Treats 15 Nano-rare Patients, More Expected

    BUSINESSWIRE

    n-Lorem Shares Guide For Toxic Gain Mutation Treatment

    BUSINESSWIRE

    n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors

    BUSINESSWIRE

    n-Lorem Foundation Welcomes New Member Alan Lotvin to Its Board of Directors

    BUSINESSWIRE

    n-Lorem, Hongene Partner for Nano-Rare ASO Medicines

    BUSINESSWIRE

    n-Lorem, Across Healthcare Platform For Nano-Rare Patients

    BUSINESSWIRE

    n-Lorem Provides Update on Progress to Help Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Unveils Limited Edition Holiday Ornament to Provide ASO Therapies

    BUSINESSWIRE

    Stanley Crooke, Named One of San Diego’s Most Influential People

    BUSINESSWIRE

    n-Lorem Convenes Annual Nano-rare Patient Colloquium to Share Accomplishments

    BUSINESSWIRE

    n-Lorem Foundation Collaborates to Support Children With Extremely Rare Diseases

    BUSINESSWIRE

    n-Lorem Foundation CEO, Stanley Crooke Awarded the Steven C. Beering Award

    BUSINESSWIRE

    n-Lorem Has Industrialized the Treatment of Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Foundation Welcomes Paul Compton and Neil Shneider to Board of Directors

    BUSINESSWIRE

    n-Lorem Foundation Initiates Clinical Trials for Three Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research

    BUSINESSWIRE

    n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Introduces First ‘Partner in Excellence’ in Nano-rare Patients

    BUSINESSWIRE

    n-Lorem Launches its Patient Empowerment Program

    BUSINESSWIRE

    Parexel and n-Lorem Foundation Partner for New Investigational Therapies

    BUSINESSWIRE

    n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines

    BUSINESSWIRE

    n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer.

    BUSINESSWIRE

    n-Lorem Foundation Announces Partnership with Nitto Avecia

    BUSINESSWIRE

    n-Lorem Foundation Appoints Claire Grezemkovsky as Director of Philanthropy

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.